Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,329,730
-$76,450,007 QoQ
Shares Held
191,686
-89.1% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
#100
of 477 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Jun 30, 2021CallValue
$5,315,594
CallShares
268,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026PFM Health Sciences, LP holds $494,895,363 across 45 Biotechnology names. CYTK ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
233,171 | $62,191,369 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
219,596 | $53,750,512 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
160,768 | $38,740,264 | |
| 4 | INBX |
Inhibrx Biosciences, Inc.
|
308,385 | $29,219,478 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
143,222 | $26,822,616 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
253,358 | $18,870,103 | |
| 7 | CYTK |
Cytokinetics Inc
This page
|
191,686 | $16,329,730 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
29,313 | $15,739,615 |
All Filings in CYTK
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,329,730 | 191,686 | Shares | Defined | 2026-08-14 | |
| 2024-09-30 | $92,779,737 | 1,757,192 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $95,204,662 | 1,757,192 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $123,196,731 | 1,757,192 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $146,707,960 | 1,757,192 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $70,690,595 | 2,399,545 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $78,273,157 | 2,399,545 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $84,439,988 | 2,399,545 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $109,947,151 | 2,399,545 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $119,430,025 | 2,465,016 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $96,850,478 | 2,465,016 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $90,737,238 | 2,465,016 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $112,355,429 | 2,465,016 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $112,927,713 | 3,159,701 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $33,385,967 | 1,687,012 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $5,315,594 | 268,600 | Call | Defined | 2021-08-16 | |
| 2021-03-31 | $35,736,035 | 1,536,373 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $20,180,517 | 971,151 | Shares | Defined | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||